Clinical trial

Open-label Study to Evaluate Metreleptin in Children Under 6 Years of Age With Generalised Lipodystrophy

NCT06502990

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2025-05-23

PhasePHASE3

Study timeline

Study start (actual)2025-05-23Date precision: day

Registry last updated2026-07-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Generalized Lipodystrophyunresolved

Interventions

MetreleptinDRUG · verified · RxNorm: metreleptin

Sponsors & collaborators

Amryt Pharmalead sponsor

Mapped research locations

ParisFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06502990 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.